Innate Pharma
(NASDAQ:IPHA)
$2.61
-0.02[-0.76%]
At close: Mar 1
$2.61
0[0.00%]
After Hours: 9:01AM EDT

GET A REPORT ON IPHA SENT RIGHT TO YOUR INBOX

37.5%
Overview Rating
Unpromising asset
Technicals Analysis
66
0100
Financials Analysis
20
0100

Innate Pharma Stock (NASDAQ:IPHA), Quotes and News Summary

Innate Pharma Stock (NASDAQ: IPHA) stock price, news, charts, stock research, profile.
Open$2.600
Close$2.620
Volume / Avg.2.020K / 18.413K
Day Range2.600 - 2.620
52 Wk Range1.810 - 3.570
Market Cap$210.998M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
49
Short Interest
%
Days to Cover10.51

Recent News

20%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Ratings
Sep 23
1
Nov 23
1
Strong Buy
Buy
Hold
Sell
Strong Sell
About Innate Pharma
Sector
Health Care
Industry
Biotechnology
Innate Pharma SA is a clinical-stage biotechnology company. The company is engaged in discovering an...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
IPHA
SYRS

FAQ

Q

How do I buy Innate Pharma (IPHA) stock?

A

You can purchase shares of Innate Pharma (NASDAQ: IPHA) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Innate Pharma's (IPHA) competitors?

Q

What is the target price for Innate Pharma (IPHA) stock?

A

The latest price target for Innate Pharma (NASDAQ: IPHA) was reported by HC Wainwright & Co. on Wednesday, November 15, 2023. The analyst firm set a price target for 11.50 expecting IPHA to rise to within 12 months (a possible 338.93% upside). 4 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Innate Pharma (IPHA)?

A

The stock price for Innate Pharma (NASDAQ: IPHA) is $2.62 last updated March 1, 2024 at 3:59 PM EST.

Q

Does Innate Pharma (IPHA) pay a dividend?

A

There are no upcoming dividends for Innate Pharma.

Q

When is Innate Pharma (NASDAQ:IPHA) reporting earnings?

A

Innate Pharma’s FY earnings are confirmed for Thursday, March 21, 2024.

Q

Is Innate Pharma (IPHA) going to split?

A

There is no upcoming split for Innate Pharma.

Q

What sector and industry does Innate Pharma (IPHA) operate in?

A

Innate Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch